Middleton & Co’s Eli Lilly LLY Stock Holding History

Middleton & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.9M	Buy	12,966 +286	+2%	+$290K	1.36%	20
2025 Q4	$13.6M	Buy	12,680 +573	+5%	+$548K	1.45%	21
2025 Q3	$9.24M	Buy	12,107 +11,432	+1,694%	+$8.51M	1%	34
2025 Q2	$526K	Hold	675	–	–	0.06%	112
2025 Q1	$557K	Sell	675 -61	-8%	-$50.8K	0.07%	109
2024 Q4	$568K	Hold	736	–	–	0.06%	105
2024 Q3	$652K	Hold	736	–	–	0.07%	106
2024 Q2	$666K	Hold	736	–	–	0.08%	102
2024 Q1	$573K	Sell	736 -25	-3%	-$17.8K	0.07%	107
2023 Q4	$444K	Hold	761	–	–	0.06%	112
2023 Q3	$409K	Sell	761 -26	-3%	-$13.4K	0.06%	110
2023 Q2	$369K	Hold	787	–	–	0.05%	121
2023 Q1	$270K	Hold	787	–	–	0.04%	135
2022 Q4	$288K	Hold	787	–	–	0.04%	135
2022 Q3	$254K	Hold	787	–	–	0.04%	135
2022 Q2	$255K	Hold	787	–	–	0.03%	143
2022 Q1	$225K	Hold	787	–	–	0.02%	152
2021 Q4	$217K	Buy	+787	New	+$200K	0.02%	153

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Middleton & Co's LLY Position: Q1 2026 in Review

Middleton & Co increased its Eli Lilly (LLY) stake by 2.3% in Q1 2026, buying an estimated $290K and bringing the position to 12,966 shares worth $11.9M. The position accounts for 1.36% of the portfolio, ranked #20.

Middleton & Co first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.6M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Middleton & Co held 12,966 shares of Eli Lilly worth $11.9M as of Q1 2026.
Middleton & Co bought 286 Eli Lilly shares in Q1 2026, an estimated $290K.
Eli Lilly made up 1.36% of Middleton & Co's portfolio in Q1 2026, its #20 holding.
Middleton & Co first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
Middleton & Co's Eli Lilly position peaked at $13.6M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.